Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
OF096963.1 | emblrelpat | KR 1020200119276-A/113: TREATMENT O... | 795 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF097064.1 | emblrelpat | KR 1020200119282-A/8: MIXTURE COMPO... | 10787 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF111067.1 | emblrelpat | KR 1020200144540-A/20: NUCLEIC ACID... | 4259 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF117710.1 | emblrelpat | KR 1020200131851-A/12: IL-13 RECEPT... | 8740 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF119867.1 | emblrelpat | KR 1020200132957-A/2: METHODS AND C... | 16438 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF125873.1 | emblrelpat | KR 1020200126439-A/6: HUMANIZED NON... | 99294 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF125922.1 | emblrelpat | KR 1020200126439-A/73: HUMANIZED NO... | 14781 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF125923.1 | emblrelpat | KR 1020200126439-A/74: HUMANIZED NO... | 117034 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF125925.1 | emblrelpat | KR 1020200126439-A/76: HUMANIZED NO... | 185159 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF125981.1 | emblrelpat | KR 1020200130468-A/67: ANTI-BLOOD D... | 6927 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF129903.1 | emblrelpat | KR 1020200133827-A/14: EXPRESSION V... | 795 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF129904.1 | emblrelpat | KR 1020200133827-A/15: EXPRESSION V... | 1677 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF133034.1 | emblrelpat | KR 1020200140934-A/8: NON-HUMAN ANI... | 8388 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF133035.1 | emblrelpat | KR 1020200140934-A/9: NON-HUMAN ANI... | 17210 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF133038.1 | emblrelpat | KR 1020200144576-A/5: TREATMENT OF ... | 3756 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF133199.1 | emblrelpat | KR 1020200146046-A/51: Cells Useful... | 7570 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF133200.1 | emblrelpat | KR 1020200146046-A/53: Cells Useful... | 6259 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF300344.1 | emblrelpat | KR 1020210100585-A/73: MARKER COMPO... | 4560 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF352222.1 | emblrelpat | KR 1020210148182-A/1: ENGINEERED DY... | 3581 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
OF355300.1 | emblrelpat | KR 1020210145221-A/855: IMMUNOGENIC... | 6474 bp | synthetic construct | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.